Mitochondrial Cumulative Damage Induced by Mitoxantrone: Late Onset Cardiac Energetic Impairment - Test2 - elhamkhani - TriplyDB

Mitochondrial Cumulative Damage Induced by Mitoxantrone: Late Onset Cardiac Energetic Impairment

Mitochondrial Cumulative Damage Induced by Mitoxantrone: Late Onset Cardiac Energetic Impairment

http://www.wikidata.org/entity/Q58229934

about

Drug-induced mitochondrial dysfunction and cardiotoxicity.Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.The importance of drug metabolites synthesis: the case-study of cardiotoxic anticancer drugs.Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice.Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.Mitoxantrone is More Toxic than Doxorubicin in SH-SY5Y Human Cells: A 'Chemobrain' In Vitro Study.Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells

P2860

Q36339445-CB621453-5DC1-4C14-ADCA-B54533255DB1 Q38876257-483C2782-3B65-4B79-A85A-BA859DB9CF4A Q39231153-A16FB27F-90A0-4D00-98BD-6A1D4C92FE79 Q47694093-9ACB6153-D1D5-4BEC-A25E-68C2A2BB98C7 Q48354981-3C42F360-0E6C-433D-814A-18952D078905 Q55654248-3E348FFB-F09C-47AA-8FE1-BD79D08D8BAC Q58798568-105CCC48-3DAF-4B44-A708-15A4FD72A5BF

P2860

Mitochondrial Cumulative Damage Induced by Mitoxantrone: Late Onset Cardiac Energetic Impairment

http://www.wikidata.org/entity/Q58229934

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2013

@uk

name

Mitochondrial Cumulative Damag ...... t Cardiac Energetic Impairment

@en

Mitochondrial Cumulative Damag ...... t Cardiac Energetic Impairment

@nl

type

label

Mitochondrial Cumulative Damag ...... t Cardiac Energetic Impairment

@en

Mitochondrial Cumulative Damag ...... t Cardiac Energetic Impairment

@nl

prefLabel

Mitochondrial Cumulative Damag ...... t Cardiac Energetic Impairment

@en

Mitochondrial Cumulative Damag ...... t Cardiac Energetic Impairment

@nl

P1433

Q58229934-8F13E29D-CD8E-4A5E-9AED-6A0B7EB884F6

P1476

Q58229934-64A7F6D2-E45F-401B-803F-2E677FA7A0CF

P2093

Q58229934-5B2398C1-8918-40A0-B8AF-8F5BF7EAD1DA

Q58229934-CA3EE8A7-D68A-47EC-B207-5BB546B3ACC4

P2860

Q58229934-0F476F79-0F4F-480B-A7B2-CB43D43581F6

Q58229934-32F954FE-0DCF-420C-830E-9660F3433407

Q58229934-36B15831-1741-48C8-A9FA-5B21F1EF5E66

Q58229934-3E8D2228-30E6-4866-96DE-E9F8D0DBE13B

Q58229934-499B3118-FB73-44E2-8EE4-E24EFE488C4E

Q58229934-4DFB884F-8560-4C24-8474-CE6F0D1A69DE

Q58229934-50EE53B0-422F-44F9-A622-31790E9FF6D2

Q58229934-710C72C5-F1FF-4010-8D05-5271A4E4F00C

Q58229934-766B4283-C29B-4F09-825D-7EA7CD4C17D8

Q58229934-8D146D86-2624-439B-AACF-FA48C16101B3

P2888

Q58229934-C5A1FA7D-E9DA-41E3-8626-F22565BE7B81

P304

Q58229934-EF4EA284-69D9-4FCE-B1C7-C8736DB98B4D

P31

Q58229934-44C57793-EB8A-4FE5-A9A5-24CD6FB98735

P356

Q58229934-C5801340-9F3B-4577-B382-F69211CAE56F

P433

Q58229934-CD987234-EF74-42B7-9CE8-5720F7B67882

P478

Q58229934-0A0C3489-5E4E-45EA-A391-94D46D5FD3ED

P50

Q58229934-09DAA0F5-F599-4615-90A2-88E8C2495EEC

Q58229934-31E04167-7A97-4343-9767-D35B07210CE4

Q58229934-74278731-C450-4159-B226-84C67E61B60D

Q58229934-8D2C2510-E7DF-4788-8CA7-EAE40B1E0D12

Q58229934-C509C43A-95A4-4F14-86EA-DEC29FF1DE00

Q58229934-DDEAB766-30AB-4796-B9D8-9B04ACB37F23

Q58229934-E12A9352-E5D6-475F-A167-EA15BFF5CB7E

Q58229934-E4AD33EA-8D18-4E99-8442-D501BD942315

Q58229934-E816B3B2-4545-490B-BC95-8B1B66B69F3D

Q58229934-F97A1041-DFB3-457F-A406-90FB9EB1DDDF

P577

Q58229934-08956F70-4750-4C9C-AA94-193234C0719B

P698

Q58229934-E87A2D5E-D610-4115-87D0-65129F2823FA

P921

Q58229934-E1FD43C0-583E-40A2-A0C4-D622A1DD4F83

P356

S12012-013-9230-2

P1433

Cardiovascular Toxicology

P1476

Mitochondrial Cumulative Damag ...... t Cardiac Energetic Impairment

@en

P2093

Eliane Dallegrave

http://www.w3.org/2001/XMLSchema#string

Luciana Grazziotin Rossato

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of mitoxantrone on proliferation dynamics and cell-cycle progression.

Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes.

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.

Failing energetics in failing hearts.

Energy metabolism in heart failure.

Is the failing heart energy starved? On using chemical energy to support cardiac function.

Toxicity of the topoisomerase II inhibitors.

Pharmacokinetics and metabolism of mitoxantrone. A review.

Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event.

Pharmacokinetics of mitoxantrone in man and laboratory animals.

P2888

s12012-013-9230-2

P304

30-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12012-013-9230-2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Vera Marisa Costa

Fernando Remião

Maria de Lourdes Bastos

Ricardo Jorge Dinis-Oliveira

Francisco Amado

José A. Duarte

Carlos M. Palmeira

P577

2013-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24096626

http://www.w3.org/2001/XMLSchema#string

P921